产品
编 号：F451836
分子式：C16H8Cl4N2O2
分子量：402.06
分子式：C16H8Cl4N2O2
分子量：402.06
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
1mg
160
In-stock
5mg
400
In-stock
10mg
640
In-stock
25mg
1200
In-stock
50mg
1971
In-stock
100mg
3200
In-stock
结构图
CAS No: 76150-91-9
产品详情
生物活性：
TCPOBOP is a constitutive androstane receptor (CAR) agonist that induces robust hepatocyte proliferation and hepatomegaly without any liver injury or tissue loss. TCPOBOP attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.
体内研究：
TCPOBOP (oral; 3 mg/kg; 1-5 days) remarkable increases Liver weight to body weight in LW/BW ratio at 48 hours.Animal Model:METfl/fl: Tam-Cre+/+ mice with a targeted deletion for exon 16 with MET KO
Dosage:3 mg/kg
Administration:Oral; 1, 2, 5 days
Result:Increased Liver weight to body weight.
TCPOBOP is a constitutive androstane receptor (CAR) agonist that induces robust hepatocyte proliferation and hepatomegaly without any liver injury or tissue loss. TCPOBOP attenuates Fas-induced murine liver injury by altering Bcl-2 proteins.
体内研究：
TCPOBOP (oral; 3 mg/kg; 1-5 days) remarkable increases Liver weight to body weight in LW/BW ratio at 48 hours.Animal Model:METfl/fl: Tam-Cre+/+ mice with a targeted deletion for exon 16 with MET KO
Dosage:3 mg/kg
Administration:Oral; 1, 2, 5 days
Result:Increased Liver weight to body weight.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备